| __timestamp | Perrigo Company plc | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 152500000 | 4101058 |
| Thursday, January 1, 2015 | 187800000 | 10763215 |
| Friday, January 1, 2016 | 184000000 | 5579049 |
| Sunday, January 1, 2017 | 167700000 | 32051299 |
| Monday, January 1, 2018 | 218600000 | 24482286 |
| Tuesday, January 1, 2019 | 187400000 | 43892589 |
| Wednesday, January 1, 2020 | 177700000 | 44505000 |
| Friday, January 1, 2021 | 122000000 | 79406000 |
| Saturday, January 1, 2022 | 123100000 | 49283000 |
| Sunday, January 1, 2023 | 122500000 | 17282730 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, from 2014 to 2023, Verona Pharma plc and Perrigo Company plc have demonstrated contrasting strategies in their R&D expenditures.
Perrigo Company plc, a leader in the over-the-counter healthcare sector, consistently invested in R&D, with a peak in 2018, spending approximately 2.2 times more than its 2023 investment. Despite a downward trend, Perrigo's commitment to innovation remains evident.
Conversely, Verona Pharma plc, a specialist in respiratory diseases, showed a remarkable increase in R&D spending, peaking in 2021 with a 19-fold increase from 2014. This surge underscores Verona's aggressive pursuit of breakthrough therapies.
These investment patterns highlight the strategic priorities of each company, reflecting their commitment to advancing healthcare solutions.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Verona Pharma plc
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Perrigo Company plc
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Verona Pharma plc
R&D Spending Showdown: Halozyme Therapeutics, Inc. vs Perrigo Company plc
R&D Insights: How Verona Pharma plc and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Verona Pharma plc and Viridian Therapeutics, Inc.
Ultragenyx Pharmaceutical Inc. or Perrigo Company plc: Who Invests More in Innovation?
Perrigo Company plc or ImmunityBio, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Perrigo Company plc and Bausch Health Companies Inc.
Research and Development Investment: Perrigo Company plc vs Novavax, Inc.
Perrigo Company plc vs Xencor, Inc.: Strategic Focus on R&D Spending